Cat.#: ACPP-1332
| Despition | GAD65 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1835 | Human RP9 Protein (AC1835) | 5 µg | inquiry |
| ACPP-1007 | Recombinant Human Secretogranin 3 Protein (6×His Tag) (AC1007) | 50 µg | inquiry |
| ACPP-1702 | Human PCSK1N Protein (AC1702) | 2 µg | inquiry |
| ACPP-1062 | Recombinant Human TYRO3 Protein (Fc Tag) (AC1062) | 50 µg | inquiry |
| ACPP-1501 | Human STX2 Protein (AC1501) | 2 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1130 | Native Bovine GFAP Protein (AC1130) | 25 µl | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.